Clinical Trial Update: Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update assesses the tolerability, safety, and pharmacokinetics of CRA-024781 in cancer patients and indicates the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Neoplasms

Drugs mentioned

• CRA-024781 (CRA-024781)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Hematologic Neoplasms, Neoplasms | Phase 1 | Status: COMPLETED